# Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients

> **NCT02746783** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Lausanne Hospitals** · enrollment: 163 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Single dose MUTAGRIP® influenza vaccine
- **DRUG:** Double dose of MUTAGRIP® influenza vaccine

## Key facts

- **NCT ID:** NCT02746783
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2020-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02746783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02746783, "Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02746783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*